Vireo Growth (VREOF) Equity Average (2020 - 2026)
Vireo Growth's (VREOF) quarterly Equity Average came in at $300.8 million in Q1 2026, up 466.92% year-on-year from $53.0 million in Q1 2025, and up 8.63% quarter-over-quarter from $276.9 million in Q4 2025.
Vireo Growth (VREOF) Equity Average (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Equity Average across 7 years of filings, most recently posting $300.8 million for Q1 2026.
- Equity Average for Q1 2026 came in at $300.8 million, up 466.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $300.8 million (up 466.92% YoY), and the FY2025 annual result was $181.5 million, up 817.68% from the prior year.
- Equity Average came in at $300.8 million for Q1 2026 at Vireo Growth, up from $276.9 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $300.8 million in Q1 2026 to a low of -$22.6 million in Q2 2024.
- The 5-year median for Equity Average is $20.2 million (2022), against an average of $63.2 million.
- Across the five-year window, Equity Average plunged 2912.27% in 2024 and soared 1634.13% in 2025, its largest moves.
- Vireo Growth's Equity Average stood at $10.0 million in 2022, then slumped by 245.09% to -$14.4 million in 2023, then surged by 254.33% to $22.3 million in 2024, then surged by 1141.58% to $276.9 million in 2025, then increased by 8.63% to $300.8 million in 2026.
- The last three Equity Average figures came in at $300.8 million (Q1 2026), $276.9 million (Q4 2025), and $257.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | Vireo Growth | - | - | 59.30 Mn | 300.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300.75 Mn |
| Dec 31, 2025 | 276.85 Mn |
| Sep 30, 2025 | 257.44 Mn |
| Jun 30, 2025 | 159.54 Mn |
| Mar 31, 2025 | 53.05 Mn |
| Dec 31, 2024 | 22.30 Mn |
| Sep 30, 2024 | -16.78 Mn |
| Jun 30, 2024 | -22.57 Mn |
| Mar 31, 2024 | -19.31 Mn |
| Dec 31, 2023 | -14.45 Mn |
| Sep 30, 2023 | -10.39 Mn |
| Jun 30, 2023 | -5.00 Mn |
| Mar 31, 2023 | 686,615.00 |
| Dec 31, 2022 | 9.96 Mn |
| Sep 30, 2022 | 20.24 Mn |
| Jun 30, 2022 | 26.54 Mn |
| Mar 31, 2022 | 36.04 Mn |
| Dec 31, 2021 | 48.41 Mn |
| Sep 30, 2021 | 56.79 Mn |
| Jun 30, 2021 | 62.52 Mn |